Skip to main content
NCBI home page
Heart logoLink to Heart
. 1996 Oct;76(4):295–298. doi: 10.1136/hrt.76.4.295

Alterations of coronary blood flow and myocardial perfusion in hypercholesterolaemia.

V Schächinger 1, A M Zeiher 1
PMCID: PMC484536  PMID: 8983671

Full text

PDF
295

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson T. J., Meredith I. T., Yeung A. C., Frei B., Selwyn A. P., Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995 Feb 23;332(8):488–493. doi: 10.1056/NEJM199502233320802. [DOI] [PubMed] [Google Scholar]
  2. Arnal J. F., Münzel T., Venema R. C., James N. L., Bai C. L., Mitch W. E., Harrison D. G. Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability. J Clin Invest. 1995 Jun;95(6):2565–2572. doi: 10.1172/JCI117957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bassenge E., Busse R. Endothelial modulation of coronary tone. Prog Cardiovasc Dis. 1988 Mar-Apr;30(5):349–380. doi: 10.1016/0033-0620(88)90003-5. [DOI] [PubMed] [Google Scholar]
  4. Benzuly K. H., Padgett R. C., Kaul S., Piegors D. J., Armstrong M. L., Heistad D. D. Functional improvement precedes structural regression of atherosclerosis. Circulation. 1994 Apr;89(4):1810–1818. doi: 10.1161/01.cir.89.4.1810. [DOI] [PubMed] [Google Scholar]
  5. Berliner J. A., Navab M., Fogelman A. M., Frank J. S., Demer L. L., Edwards P. A., Watson A. D., Lusis A. J. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 1995 May 1;91(9):2488–2496. doi: 10.1161/01.cir.91.9.2488. [DOI] [PubMed] [Google Scholar]
  6. Casino P. R., Kilcoyne C. M., Quyyumi A. A., Hoeg J. M., Panza J. A. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation. 1993 Dec;88(6):2541–2547. doi: 10.1161/01.cir.88.6.2541. [DOI] [PubMed] [Google Scholar]
  7. Cohen R. A., Vanhoutte P. M. Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP. Circulation. 1995 Dec 1;92(11):3337–3349. doi: 10.1161/01.cir.92.11.3337. [DOI] [PubMed] [Google Scholar]
  8. Cohen R. A., Zitnay K. M., Haudenschild C. C., Cunningham L. D. Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ Res. 1988 Nov;63(5):903–910. doi: 10.1161/01.res.63.5.903. [DOI] [PubMed] [Google Scholar]
  9. Cooke J. P., Singer A. H., Tsao P., Zera P., Rowan R. A., Billingham M. E. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992 Sep;90(3):1168–1172. doi: 10.1172/JCI115937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Creager M. A., Cooke J. P., Mendelsohn M. E., Gallagher S. J., Coleman S. M., Loscalzo J., Dzau V. J. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990 Jul;86(1):228–234. doi: 10.1172/JCI114688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Drexler H., Zeiher A. M., Meinzer K., Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 1991 Dec 21;338(8782-8783):1546–1550. doi: 10.1016/0140-6736(91)92372-9. [DOI] [PubMed] [Google Scholar]
  12. Egashira K., Hirooka Y., Kai H., Sugimachi M., Suzuki S., Inou T., Takeshita A. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation. 1994 Jun;89(6):2519–2524. doi: 10.1161/01.cir.89.6.2519. [DOI] [PubMed] [Google Scholar]
  13. Egashira K., Inou T., Hirooka Y., Yamada A., Urabe Y., Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med. 1993 Jun 10;328(23):1659–1664. doi: 10.1056/NEJM199306103282302. [DOI] [PubMed] [Google Scholar]
  14. Fleisher L. N., Tall A. R., Witte L. D., Miller R. W., Cannon P. J. Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins. J Biol Chem. 1982 Jun 25;257(12):6653–6655. [PubMed] [Google Scholar]
  15. Förstermann U., Closs E. I., Pollock J. S., Nakane M., Schwarz P., Gath I., Kleinert H. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension. 1994 Jun;23(6 Pt 2):1121–1131. doi: 10.1161/01.hyp.23.6.1121. [DOI] [PubMed] [Google Scholar]
  16. Gould K. L., Martucci J. P., Goldberg D. I., Hess M. J., Edens R. P., Latifi R., Dudrick S. J. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium. Circulation. 1994 Apr;89(4):1530–1538. doi: 10.1161/01.cir.89.4.1530. [DOI] [PubMed] [Google Scholar]
  17. Lee R. T., Kamm R. D. Vascular mechanics for the cardiologist. J Am Coll Cardiol. 1994 May;23(6):1289–1295. doi: 10.1016/0735-1097(94)90369-7. [DOI] [PubMed] [Google Scholar]
  18. Lenfant C. NHLBI funding policies. Enhancing stability, predictability, and cost control. Circulation. 1994 Jul;90(1):1–1. doi: 10.1161/01.cir.90.1.1. [DOI] [PubMed] [Google Scholar]
  19. Leung W. H., Lau C. P., Wong C. K. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet. 1993 Jun 12;341(8859):1496–1500. doi: 10.1016/0140-6736(93)90634-s. [DOI] [PubMed] [Google Scholar]
  20. Levine G. N., Keaney J. F., Jr, Vita J. A. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med. 1995 Feb 23;332(8):512–521. doi: 10.1056/NEJM199502233320807. [DOI] [PubMed] [Google Scholar]
  21. Lopez J. A., Armstrong M. L., Piegors D. J., Heistad D. D. Effect of early and advanced atherosclerosis on vascular responses to serotonin, thromboxane A2, and ADP. Circulation. 1989 Mar;79(3):698–705. doi: 10.1161/01.cir.79.3.698. [DOI] [PubMed] [Google Scholar]
  22. Matsuda Y., Hirata K., Inoue N., Suematsu M., Kawashima S., Akita H., Yokoyama M. High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation. Circ Res. 1993 May;72(5):1103–1109. doi: 10.1161/01.res.72.5.1103. [DOI] [PubMed] [Google Scholar]
  23. Minor R. L., Jr, Myers P. R., Guerra R., Jr, Bates J. N., Harrison D. G. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest. 1990 Dec;86(6):2109–2116. doi: 10.1172/JCI114949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Myers P. R., Minor R. L., Jr, Guerra R., Jr, Bates J. N., Harrison D. G. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature. 1990 May 10;345(6271):161–163. doi: 10.1038/345161a0. [DOI] [PubMed] [Google Scholar]
  25. Mügge A., Elwell J. H., Peterson T. E., Harrison D. G. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity. Am J Physiol. 1991 Feb;260(2 Pt 1):C219–C225. doi: 10.1152/ajpcell.1991.260.2.C219. [DOI] [PubMed] [Google Scholar]
  26. Nabel E. G., Selwyn A. P., Ganz P. Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate. Circulation. 1990 Mar;81(3):850–859. doi: 10.1161/01.cir.81.3.850. [DOI] [PubMed] [Google Scholar]
  27. Navab M., Imes S. S., Hama S. Y., Hough G. P., Ross L. A., Bork R. W., Valente A. J., Berliner J. A., Drinkwater D. C., Laks H. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest. 1991 Dec;88(6):2039–2046. doi: 10.1172/JCI115532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Ohara Y., Peterson T. E., Harrison D. G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 1993 Jun;91(6):2546–2551. doi: 10.1172/JCI116491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ohara Y., Peterson T. E., Sayegh H. S., Subramanian R. R., Wilcox J. N., Harrison D. G. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation. 1995 Aug 15;92(4):898–903. doi: 10.1161/01.cir.92.4.898. [DOI] [PubMed] [Google Scholar]
  30. Palmer R. M., Ashton D. S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988 Jun 16;333(6174):664–666. doi: 10.1038/333664a0. [DOI] [PubMed] [Google Scholar]
  31. Pohl U., Holtz J., Busse R., Bassenge E. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension. 1986 Jan;8(1):37–44. doi: 10.1161/01.hyp.8.1.37. [DOI] [PubMed] [Google Scholar]
  32. Quyyumi A. A., Dakak N., Andrews N. P., Gilligan D. M., Panza J. A., Cannon R. O., 3rd Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation. 1995 Aug 1;92(3):320–326. doi: 10.1161/01.cir.92.3.320. [DOI] [PubMed] [Google Scholar]
  33. Quyyumi A. A., Dakak N., Andrews N. P., Husain S., Arora S., Gilligan D. M., Panza J. A., Cannon R. O., 3rd Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest. 1995 Apr;95(4):1747–1755. doi: 10.1172/JCI117852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schächinger V., Zeiher A. M. Quantitative assessment of coronary vasoreactivity in humans in vivo. Importance of baseline vasomotor tone in atherosclerosis. Circulation. 1995 Oct 15;92(8):2087–2094. doi: 10.1161/01.cir.92.8.2087. [DOI] [PubMed] [Google Scholar]
  35. Shimokawa H., Flavahan N. A., Vanhoutte P. M. Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries. Circulation. 1991 Feb;83(2):652–660. doi: 10.1161/01.cir.83.2.652. [DOI] [PubMed] [Google Scholar]
  36. Tanner F. C., Noll G., Boulanger C. M., Lüscher T. F. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation. 1991 Jun;83(6):2012–2020. doi: 10.1161/01.cir.83.6.2012. [DOI] [PubMed] [Google Scholar]
  37. Treasure C. B., Klein J. L., Weintraub W. S., Talley J. D., Stillabower M. E., Kosinski A. S., Zhang J., Boccuzzi S. J., Cedarholm J. C., Alexander R. W. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995 Feb 23;332(8):481–487. doi: 10.1056/NEJM199502233320801. [DOI] [PubMed] [Google Scholar]
  38. Vane J. R., Anggård E. E., Botting R. M. Regulatory functions of the vascular endothelium. N Engl J Med. 1990 Jul 5;323(1):27–36. doi: 10.1056/NEJM199007053230106. [DOI] [PubMed] [Google Scholar]
  39. Yang Z. H., Richard V., von Segesser L., Bauer E., Stulz P., Turina M., Lüscher T. F. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? Circulation. 1990 Jul;82(1):188–195. doi: 10.1161/01.cir.82.1.188. [DOI] [PubMed] [Google Scholar]
  40. Zeiher A. M., Drexler H., Saurbier B., Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest. 1993 Aug;92(2):652–662. doi: 10.1172/JCI116634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Zeiher A. M., Drexler H., Wollschlaeger H., Saurbier B., Just H. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol. 1989 Nov 1;14(5):1181–1190. doi: 10.1016/0735-1097(89)90414-2. [DOI] [PubMed] [Google Scholar]
  42. Zeiher A. M., Drexler H., Wollschläger H., Just H. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation. 1991 Nov;84(5):1984–1992. doi: 10.1161/01.cir.84.5.1984. [DOI] [PubMed] [Google Scholar]
  43. Zeiher A. M., Drexler H., Wollschläger H., Just H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991 Feb;83(2):391–401. doi: 10.1161/01.cir.83.2.391. [DOI] [PubMed] [Google Scholar]
  44. Zeiher A. M., Fisslthaler B., Schray-Utz B., Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res. 1995 Jun;76(6):980–986. doi: 10.1161/01.res.76.6.980. [DOI] [PubMed] [Google Scholar]
  45. Zeiher A. M., Krause T., Schächinger V., Minners J., Moser E. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation. 1995 May 1;91(9):2345–2352. doi: 10.1161/01.cir.91.9.2345. [DOI] [PubMed] [Google Scholar]
  46. Zeiher A. M., Schächlinger V., Hohnloser S. H., Saurbier B., Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation. 1994 Jun;89(6):2525–2532. doi: 10.1161/01.cir.89.6.2525. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES